Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Ready for your complex CTO cases, offering exceptional deliverability1 and enhanced visibility1 where and when you need it most.
Core Wire Technology — enabling thinner struts with enhanced radiopacity,1 achieved by incorporating a platinum iridium core within a cobalt alloy outer shell.
Proven to perform in a real-world patient population with chronic total occlusions, Resolute DES demonstrated clinical and procedural outcomes.2DOWNLOAD STUDY
Examine 5-year safety and efficacy data for the Resolute Zotarolimus-Eluting stent.4DOWNLOAD CTO ANALYSIS
Resolute Onyx™ DES features excellent deliverability,1 visibility,1 and a generous size matrix2 — with demonstrated procedural success in challenging PCI cases.2MORE ABOUT
Compared with Resolute Integrity™ DES in benchtop testing. Data on file at Medtronic. May not be indicative of clinical performance.
Resolute Onyx™ DES IFU.
The Resolute Onyx stents should not be expanded to a diameter beyond the maximum labeled diameter listed on the label per the IFU. Postdilatation required for overexpansion.
Yeh, et al. Five-Year Clinical Outcomes for Resolute Zotarolimus-Eluting Stents in Total Occlusions. Presented at TCT 2018.
©2019 Medtronic. All rights reserved. Medtronic, Medtronic logo, and Further, Together are trademarks of Medtronic. ™*Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company. For distribution in the USA only.